David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 2,475 shares at $19.79 ($49K) on 2026-01-20, disclosed to the SEC on 2026-01-21.
Seasonal sale ($49k) by General Counsel — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| APLS | SELL | 2025-12-18 | $245K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |
| APLS | SELL | 2025-10-17 | $126K | — | Filing → |